Canada· CA-DIN-02398028
PLIAGLIS
A lidocain, kombinationen product containing tetracaine + lidocaine, registered in Canada by SCIENCES DE LA PEAU CRESCITA INC. / CRESCITA SKIN SCIENCES INC.. The same ATC class is registered in 11 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Lidocain, kombinationen is registered in 11 of 19 countries.
Countries holding a registration under ATC N01BB52 (lidocain, kombinationen), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 7 of them publish a price we can compare per daily dose
Lidocain, kombinationen · ATC N01BB52
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- TETRACAINE + LIDOCAINE
- Manufacturer
- SCIENCES DE LA PEAU CRESCITA INC. / CRESCITA SKIN SCIENCES INC.
- Country
- Canada (CA)
- ATC code
- N01BB52
- ATC class
- Lidocain, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lidocain, kombinationen in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesBlockaidSofTap Inc
- GermanyPliaglisCroma Pharma Gmbh
- United KingdomPliaglis 70mg/g / 70mg/g creamCroma-Pharma GmbH
- NetherlandsPliaglis 70 mg/g + 70 mg/g crèmeCroma Pharma GmbH
- CzechiaPLIAGLISEgis Pharmaceuticals PLC, Budapešť
- SwedenRapydan 70 mg/70 mg Medicinskt plåsterEurocept International B.V.
- NorwayRapydanEurocept International B.V
- SpainPLIAGLIS 70 MG/G + 70 MG/G CREMAIndustrial Farmaceutica Cantabria S.A.
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Pliaglis, Rapydan
- Belgium · Pliaglis, Rapydan
- Bulgaria · Плиаглис
- Czechia · Pliaglis
- Germany · Pliaglis, Rapydan
- Denmark · Pliapel, Ralydan
- Spain · Pliaglis
- United Kingdom (Northern Ireland) · Pliaglis, Rapydan
- Greece · Pliaglis
- Hungary · Pliapeel
- Ireland · Pliaglis
- Italy · Pliaglis
- Lithuania · Cessolute
- Luxembourg · Pliaglis, Rapydan
- Latvia · Cessolute
- Netherlands · Pliaglis, Rapydan
- Norway · Pliapel, Rapydan
- Poland · Pliaglis
- Portugal · Pliaglis
- Sweden · Rapydan
- Slovakia · Pliaglis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/61063fb2-cd26-4103-9eae-119b1439ddfb GET /v1/drugs/61063fb2-cd26-4103-9eae-119b1439ddfb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02398028",
"form": "CREAM",
"class": "Human",
"routes": [
"TOPICAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "N01BB52",
"schedule": [
"Prescription"
],
"drug_code": "88297",
"strengths": [
"7 %"
],
"ahfs_class": null,
"substances": [
"TETRACAINE",
"LIDOCAINE"
],
"product_categorization": null
}See everything about lidocain, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.